CORT   $42.28  3.32% Market Closed After Close 42.5 0.52%

Corcept Therapeutics Inc
Total Cash 473.16M
totalCashPerShare 4.528
EBITDA 128.58M
Total Debt 5.67M
quickRatio 5.254
currentRatio 5.567
Total Revenue 569.61M
debtToEquity 0.951
Revenue/Share 5.553
ROA 0.12905
ROE 0.24755
grossProfits
freeCashflow 124.42M
operatingCashflow 123.73M
earningsGrowth 0.28
revenueGrowth 0.391
grossMargins 0.98494005
ebitdaMargins 0.22573
operatingMargins 0.22035
profitMargins 0.22117001
enterpriseValue 3.51B
forwardPE 22.550295
floatShares 85.37M
sharesOutstanding 104.49M
sharesShort 22.09M
sharesShortPriorMonth 22.26M
dateShortInterest
sharesPercentSharesOut 0.21%
heldPercentInsiders 0.12%
heldPercentInstitutions 0.87%
Short Ratio help_outline 26.86%
shortPercentOfFloat 0.30%
impliedSharesOutstanding
bookValue 5.711
Price To Book help_outline 6.67
earningsQuarterlyGrowth 0.29
netIncomeToCommon 124.96M
trailingEps 1.13%
forwardEps 1.69%
enterpriseToEbitda 27.34
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.27 3Q 2024
institutionsCount 395
lastUpdated Sept. 16, 2024, 12:26 p.m.